Anna Suk-Fong Lok, MD, DSc (Hon), FAASLD, AGAF 駱淑芳

Dr. Lok graduated from the University of Hong Kong Medical School. She completed her hepatology training in London under Dame Sheila Sherlock at the Royal Free Hospital in London. She served as faculty at the University of Hong Kong until she moved to the United States in 1992. She joined the University of Michigan in 1995 and is currently the Director of the Hepatology Program and Assistant Dean for Clinical Research.

Dr. Lok’s research focuses on natural history and treatment of hepatitis B and C. She has also conducted research on prevention and early diagnosis of hepatocellular carcinoma and risk factors for non-alcoholic fatty liver disease progression and outcomes. Dr. Lok has published more than 550 papers on viral hepatitis and liver diseases including the American Association for the Study of Liver Diseases (AASLD) guidelines on “Hepatitis B”.

She served as Associate Editor of HEPATOLOGY in 2002-6, co-Editor of Journal of Viral Hepatitis in 2007-9, Senior Associate Editor of GASTROENTEROLOGY in 2011-2012, and President of AASLD in 2017.

Dr. Lok has mentored more than 50 fellows and junior faculty from all over the world, many of whom have become full professors and heads of departments.

She received many awards throughout her career including the Distinguished Scientist Award from the Hepatitis B Foundation in 2008, the Distinguished Service Award from the AASLD in 2011, the William Beaumont Prize in Gastroenterology from the American Gastroenterological Association in 2016, a Gold Medal Award from the Canadian Association for the Study of the Liver and an Hon DSc from the University of Hong Kong in 2017, an International Recognition Award from the European Association for the Study of the Liver in 2018, and a Distinguished University Professorship from the University of Michigan in 2019.